Clearpoint Neuro Inc (CLPT)
Clearpoint Neuro stock today
Clearpoint Neuro closed at $10.67 on October 30, 2026, down 0.19% on the day. Over the past year it returned -54.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $325 million.
| Period | CLPT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -12.6% | -0.9% |
| 3 months | -26.8% | +2.1% |
| Year to date | -22.0% | +11.7% |
| 1 year | -54.9% | +12.4% |
| 3 years | +96.9% | +88.5% |
| 5 years | -36.2% | +76.0% |
Key statistics
- Market value
- $325M
- Price / sales
- 7.1
- 52-week range
- $8.66 to $23.68
About Clearpoint Neuro
Clearpoint Neuro develops neuromodulation devices for treating neurological and psychiatric conditions.
Sector: Health Care
More on Clearpoint Neuro
- Financials: revenue, earnings and segmentsRevenue +18% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $2,200 today
No forecast, no recommendation. This page describes Clearpoint Neuro Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.